Clinical Trials Directory

Trials / Completed

CompletedNCT03643302

Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation

Clinical Efficacy and Safety of Tran-bronchoscopy Airway Clearance and Bronchoalveolar Lavage in the Treatment of Moderate to Severe Bronchiectasis With Acute Exacerbation

Status
Completed
Phase
Study type
Observational
Enrollment
189 (actual)
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

No study have evaluated the efficacy and safety of airway clearance therapy (ACT) and bronchoalveolar lavage (BAL) under bronchoscope for bronchiectasis. This study aimed to evaluate the clinical efficacy and safety of tran-bronchoscopy airway clearance and bronchoalveolar lavage in the treatment of moderate to severe bronchiectasis with acute exacerbation:A randomized, prospective cohort study.

Detailed description

The aim of this study was to evaluate the efficacy and safety of ACT combined with BAL for bronchiectasis patients with acute exacerbation through the whole study process, which will provide a high quality of evidence-based strategies for the treatment, revision and optimization of international and domestic clinical guidelines for bronchiectasis. All the participants will be required to check the various efficacy and safety indicators.

Conditions

Interventions

TypeNameDescription
DEVICEVersion BF-1T26 electronic bronchoscopeInterventions involving the therapy of airway clearance and bronchoalveolar lavage by Version BF-1T26 electronic bronchoscope

Timeline

Start date
2018-02-01
Primary completion
2019-02-28
Completion
2019-03-18
First posted
2018-08-22
Last updated
2020-10-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03643302. Inclusion in this directory is not an endorsement.

Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation (NCT03643302) · Clinical Trials Directory